Breakthrough in Aggressive TNBC Subtype A landmark study published in Science Translational Medicine reveals a previously unrecognized therapeutic vulnerability in an aggressive subtype of triple-negative breast cancer (TNBC). Conducted by researchers at The University of Texas MD Anderson Cancer Center, the work provides new insight into how this hard-to-treat cancer might be targeted more effectively…